Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Executive VP and CFO of H.B. Fuller, John J. Corkrean, filed a Form 4 detailing changes in beneficial ownership, including the acquisition of phantom units and adjustments to stock options and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 with the SEC.
- The filing reports changes in beneficial ownership of H.B. Fuller stock.
- Corkrean acquired 98.52 phantom units convertible into common stock on May 10, 2024, at a price of $79.62.
- He directly owns 47,187 shares of common stock.
- The filing also details holdings of employee stock options and restricted stock units with various vesting schedules and expiration dates.
- These holdings include options to buy common stock at prices ranging from $43.48 to $77.72.
- Restricted stock units vest in three annual installments.
- The report includes stock units and restricted stock units acquired through dividend equivalent features.
Sentiment
Score: 5
Explanation: This is a routine filing, and the information presented doesn't inherently indicate positive or negative sentiment. It simply reflects changes in the executive's holdings.
Positives
- The reporting person's continued holding of a significant number of shares and stock options indicates confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is typical for executives who receive stock options and restricted stock units as part of their compensation.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of the options are within typical ranges for similar companies.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the executive's stake in the company.
- It can influence investor sentiment depending on the perceived implications of the reported transactions.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $43.48 and an expiration date of 05/17/2026. |
| 01/26/2018 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $50.1 and an expiration date of 01/26/2027. |
| 01/25/2019 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $53.57 and an expiration date of 01/25/2028. |
| 01/24/2020 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $45.05 and an expiration date of 01/24/2029. |
| 01/24/2021 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $48.35 and an expiration date of 01/24/2030. |
| 01/27/2022 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $51.89 and an expiration date of 01/27/2031. |
| 01/24/2023 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $72.94 and an expiration date of 01/24/2032. Date of vesting for Restricted Stock Units. |
| 01/24/2024 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $68.17 and an expiration date of 01/24/2033. Date of vesting for Restricted Stock Units. |
| 01/26/2025 | Date of exercisable Employee Stock Option (Right-to-Buy) with an exercise price of $77.72 and an expiration date of 01/26/2034. Date of vesting for Restricted Stock Units. |
| 05/10/2024 | Date of transaction: Acquisition of phantom units. |
| 05/14/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.